DK0647229T3 - Diaminsalte af clavulansyre - Google Patents

Diaminsalte af clavulansyre

Info

Publication number
DK0647229T3
DK0647229T3 DK94911952.3T DK94911952T DK0647229T3 DK 0647229 T3 DK0647229 T3 DK 0647229T3 DK 94911952 T DK94911952 T DK 94911952T DK 0647229 T3 DK0647229 T3 DK 0647229T3
Authority
DK
Denmark
Prior art keywords
clavulanic acid
diamine salts
salts
diamine
new
Prior art date
Application number
DK94911952.3T
Other languages
Danish (da)
English (en)
Inventor
Pieter Gijsbert Weber
Original Assignee
Gist Brocades Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gist Brocades Nv filed Critical Gist Brocades Nv
Application granted granted Critical
Publication of DK0647229T3 publication Critical patent/DK0647229T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D503/00—Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pyrrole Compounds (AREA)
DK94911952.3T 1993-03-26 1994-03-22 Diaminsalte af clavulansyre DK0647229T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP93200872 1993-03-26
PCT/EP1994/000919 WO1994022873A1 (en) 1993-03-26 1994-03-22 Diamine salts of clavulanic acid
US08/457,985 US5719277A (en) 1993-03-26 1995-06-01 Diamine salts of clavulanic acid

Publications (1)

Publication Number Publication Date
DK0647229T3 true DK0647229T3 (da) 1996-10-07

Family

ID=26133724

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94911952.3T DK0647229T3 (da) 1993-03-26 1994-03-22 Diaminsalte af clavulansyre

Country Status (22)

Country Link
US (1) US5719277A (no)
EP (2) EP0719778A1 (no)
CN (1) CN1041933C (no)
AT (1) ATE140703T1 (no)
AU (1) AU682030B2 (no)
CA (1) CA2135671A1 (no)
CY (1) CY1966A (no)
CZ (1) CZ284855B6 (no)
DE (2) DE69400334T2 (no)
DK (1) DK0647229T3 (no)
ES (1) ES2070109T3 (no)
FI (1) FI945510A0 (no)
HK (1) HK217196A (no)
HU (1) HUT69372A (no)
IL (1) IL109139A (no)
NO (1) NO301767B1 (no)
NZ (1) NZ263564A (no)
PL (1) PL306371A1 (no)
RO (1) RO112113B1 (no)
SK (1) SK279918B6 (no)
WO (1) WO1994022873A1 (no)
ZA (1) ZA942133B (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT399155B (de) * 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
AU678752B3 (en) * 1992-06-11 1997-06-05 Smithkline Beecham Plc Process for the preparation of clavulanic acid
GB2282810B (en) * 1992-06-11 1997-02-26 Smithkline Beecham Plc Preparation or purification of clavulanic acid
SI9300296B (sl) * 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
SI9400107A (en) * 1994-03-02 1995-10-31 Lek Tovarna Farmacevtskih New process of the isolation of clavulanic acid and its pharmaceutical salts from fermented broth of streptomyces sp.p 6621 ferm p 2804.
GB9426261D0 (en) 1994-12-24 1995-02-22 Spurcourt Ltd Clavulanic acid salts
IL117217A0 (en) * 1995-02-25 1996-06-18 Spurcourt Ltd Clavulanic acid salts
SI9500134B (sl) 1995-04-20 2004-04-30 Lek, Postopek za pripravo čistih alkalijskih soli klavulanske kisline
SI9500265A1 (en) * 1995-08-28 1997-02-28 Lek Tovarna Farmacevtskih Process for purification of the aqueous fermented broth filtrate of streptomyces sp. p 6621 ferm p 2804 by ultrafiltration
US6071532A (en) * 1996-10-15 2000-06-06 Emory University Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof
WO2000004028A1 (en) * 1998-07-16 2000-01-27 Dsm N.V. Improved process for the preparation of salts and esters of clavulanic acid
US6908663B1 (en) * 2000-11-15 2005-06-21 Awi Licensing Company Pigmented radiation cured wear layer
CN105384758B (zh) * 2015-12-01 2018-05-01 国药集团威奇达药业有限公司 克拉维酸胺盐的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41109B1 (en) * 1974-04-20 1979-10-24 Beecham Group Ltd Novel -lactam antibiotic from streptomyces clavuligerus
DE3063683D1 (en) * 1979-08-24 1983-07-14 Beecham Group Plc Amine salt of clavulanic acid, its preparation and use
ES2010143A6 (es) * 1989-03-01 1989-10-16 Pharma Mar S A Pharmar Un nuevo procedimiento de obtencion del acido z(2r,5r)-3-(2-hiadroxietiliden)-7- oxo-4-oxa-1-azabiciclo(3,2,0) -heptano-2-carboxilico y de sales estares farmaceutiacamente aceptables del mismo,a partir de caldos de fermentacion de streptomyces, sp.
AT399155B (de) * 1992-03-26 1995-03-27 Lek Tovarna Farmacevtskih Neue alkylendiammonium-diclavulanat-derivate, verfahren zu deren herstellung sowie deren verwendung
SI9300296B (sl) * 1992-06-11 1998-06-30 Smithkline Beecham P.L.C. Postopek in intermedianti za pripravo klavulanske kisline
GB9305565D0 (en) * 1993-03-18 1993-05-05 Smithkline Beecham Plc Novel compounds and processes

Also Published As

Publication number Publication date
RO112113B1 (ro) 1997-05-30
HU9403383D0 (en) 1995-02-28
NO944531L (no) 1994-11-25
CA2135671A1 (en) 1994-10-13
DE69400334D1 (de) 1996-08-29
IL109139A0 (en) 1994-06-24
FI945510A (fi) 1994-11-23
SK144294A3 (en) 1995-06-07
DE647229T1 (de) 1996-01-18
FI945510A0 (fi) 1994-11-23
NZ263564A (en) 1995-12-21
NO301767B1 (no) 1997-12-08
CN1108029A (zh) 1995-09-06
PL306371A1 (en) 1995-03-20
CZ284855B6 (cs) 1999-03-17
SK279918B6 (sk) 1999-05-07
HUT69372A (en) 1995-09-28
US5719277A (en) 1998-02-17
ES2070109T1 (es) 1995-06-01
EP0719778A1 (en) 1996-07-03
ATE140703T1 (de) 1996-08-15
IL109139A (en) 1997-03-18
AU6429494A (en) 1994-10-24
HK217196A (en) 1996-12-27
AU682030B2 (en) 1997-09-18
EP0647229B1 (en) 1996-07-24
EP0647229A1 (en) 1995-04-12
WO1994022873A1 (en) 1994-10-13
DE69400334T2 (de) 1997-02-13
ZA942133B (en) 1995-02-21
CZ286394A3 (en) 1995-03-15
ES2070109T3 (es) 1996-12-01
CN1041933C (zh) 1999-02-03
NO944531D0 (no) 1994-11-25
CY1966A (en) 1997-07-04

Similar Documents

Publication Publication Date Title
DK0490823T3 (no)
ATE124405T1 (de) 1,4,7,10-tetraazacyclododecan-butyltriole, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel.
ATE187167T1 (de) Amido-3-pyrazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellungen
ATA256092A (de) Aminosäurederivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE121295T1 (de) Augentropfenarzneimittel.
DK0647229T3 (da) Diaminsalte af clavulansyre
IE820856L (en) Omega-cyano-1,omega-diphenyl-azaalkane derivatives.
DE68909412D1 (de) Salze von glykosaminoglykanen, verfahren zu ihrer herstellung und diese salze enthaltende pharmazeutische zusammensetzungen.
BR9103036A (pt) Composto,formulacao farmaceutica e processo para a preparacao do composto
DE3874358D1 (de) 4-(3h)-chinazolinon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen.
ATE143010T1 (de) Pyridazin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE3777122D1 (de) Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
GR3025951T3 (en) Alpha amino acid derivatives, a method for their preparation and pharmaceutical preparations containing them.
DE3675714D1 (de) Substituierte hexahydroarylchinolizinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
EP0331092A3 (en) Alpha-amino-carboxylic-acid derivatives, their preparation and use
DE3767894D1 (de) 1,2-dithiol-3-thion-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammenstellung.
ZA834409B (en) 1,4-dihydropyridine derivatives in optically active or in racemate form and their production and pharmaceutical compositions
EP0261524A3 (de) Arzneimittelzubereitungen
DE3586817D1 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
AU8379091A (en) New amino acid derivatives, a process for the preparation thereof and pharmaceutical composition comprising the same
ZA908298B (en) Optically active thiazetoquinoline-3-carboxylic acid compound,method for preparation thereof,and a pharmaceutical composition comprising the same
WO1995022544A3 (de) Substituierte 1,3,8-triaza-spiro(4,5)-decan-4-on-derivate als vorstufen zur herstellung von pharmazeutika
AU6629590A (en) N-(3',4'-dimethoxycinnamoyl)anthranilic acid
DE3781411D1 (de) 2-(aminoalkylthio)methyl-1,4-dihydropyridine, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
GB9020305D0 (en) New amino acid derivatives,a process for the preparation thereof and pharmaceutical composition comprising the same